EPCs and pathological angiogenesis: When good cells go bad

Microvascular Research

Volumn 79, Issue 3, 2010, Pages 207-216

  Calzi, Sergio Li ^a   Neu, Matthew B ^a   Shaw, Lynn C ^a   Kielczewski, Jennifer L ^a   Moldovan, Nicanor I ^b   Grant, Maria B ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Diabetic retinopathy; Endothelial progenitor cells; Stem cells

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; FIBROBLAST GROWTH FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; OSTEOPONTIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL POPULATION; CELL STRUCTURE; CELL SURFACE; CELL TYPE; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; EYE DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; ISCHEMIA; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETINA BLOOD VESSEL; STEM CELL;

ANGIOGENESIS INHIBITORS; ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; ENDOTHELIAL CELLS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; RETINAL NEOVASCULARIZATION; STEM CELL NICHE; STEM CELLS;

EID: 77952090934     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2010.02.011     Document Type: Article

References (73)

1. Anghelina M., et al. Monocytes and macrophages form branched cell columns in matrigel: implications for a role in neovascularization. Stem Cells Dev. 2004, 13:665-676.
2. Anghelina M., et al. A subpopulation of peritoneal macrophages form capillarylike lumens and branching patterns in vitro. J. Cell. Mol. Med. 2006, 10:708-715.
3. Asahara T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
4. Barber C.L., Iruela-Arispe M.L. The ever-elusive endothelial progenitor cell: identities, functions and clinical implications. Pediatr. Res. 2006, 59:26R-32R.
5. Bertolini F., et al. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat. Rev. Cancer 2006, 6:835-845.
6. Blinder V., Fisher S.G. The role of environmental factors in the etiology of lymphoma. Cancer Invest. 2008, 26:306-316.
7. Bronte V., et al. Tumor-induced immune dysfunctions caused by myeloid suppressor cells. J. Immunother. 2001, 24:431-446.
8. Brunner S., et al. Correlation of different circulating endothelial progenitor cells to stages of diabetic retinopathy: first in vivo data. Invest. Ophthalmol. Vis. Sci. 2009, 50:392-398.
9. Caballero S., et al. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes 2007, 56:960-967.
10. + cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp. Hematol. 2007, 35:1109-1118.
11. Cursiefen C., et al. Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea 2006, 25:443-447.
12. De Palma M., et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005, 8:211-226.
13. De Palma M., et al. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat. Med. 2003, 9:789-795.
14. Domen J., et al. Bone Marrow (Hematiopoietic) Stem Cells. Stem Cell Information: The National Institutes of Health resource for stem cell research 2006.
15. Dorrell, M.I., et al., Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen-induced retinopathy. Glia. 58, 43-54.
16. Dorrell M.I., Friedlander M. Mechanisms of endothelial cell guidance and vascular patterning in the developing mouse retina. Prog. Retin. Eye Res. 2006, 25:277-295.
17. Dorrell M.I., et al. Adult bone marrow-derived stem cells use R-cadherin to target sites of neovascularization in the developing retina. Blood 2004, 103:3420-3427.
18. Engerman R.L., et al. Cell turnover of capillaries. Lab. Invest. 1967, 17:738-743.
19. Fadini G.P., et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J. Am. Coll. Cardiol. 2005, 45:1449-1457.
20. Gao D., et al. Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim. Biophys. Acta 2009, 1796:33-40.
21. Gao D., et al. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 2008, 319:195-198.
22. Grant M.B., et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med. 2002, 8:607-612.
23. Grunewald M., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006, 124:175-189.
24. Hur J., et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 2004, 24:288-293.
25. Jankovic V., et al. Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:1260-1265.
26. + hemangiocytes. Nat. Med. 2006, 12:557-567.
27. Joussen A.M., et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. Faseb J. 2004, 18:1450-1452.
28. Kern T.S. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diab. Res. 2007, 2007:95103.
29. Khakoo A.Y., Finkel T. Endothelial progenitor cells. Annu. Rev. Med. 2005, 56:79-101.
30. Kim S.J., et al. Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis. Am. J. Pathol. 2009, 174:1972-1980.
31. Klein R., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XXII: the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008, 115:1859-1868.
32. Kopp H.G., et al. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma. Am. J. Clin. Dermatol. 2008, 9:207-217.
33. Kopp H.G., et al. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr. Opin. Hematol. 2006, 13:175-181.
34. Kubota Y., et al. M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J. Exp. Med. 2009, 206:1089-1102.
35. Kusmartsev S., Gabrilovich D.I. Immature myeloid cells and cancer-associated immune suppression. Cancer Immunol. Immunother. 2002, 51:293-298.
36. Kusmartsev S., Gabrilovich D.I. Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species. J. Leukoc. Biol. 2003, 74:186-196.
37. Kusuyama T., et al. Effects of treatment for diabetes mellitus on circulating vascular progenitor cells. J. Pharmacol. Sci. 2006, 102:96-102.
38. Lee I.G., et al. Involvement of circulating endothelial progenitor cells and vasculogenic factors in the pathogenesis of diabetic retinopathy. Eye (Lond) 2006, 20:546-552.
39. Li Calzi S., et al. Carbon monoxide and nitric oxide mediate cytoskeletal reorganization in microvascular cells via vasodilator-stimulated phosphoprotein phosphorylation: evidence for blunted responsiveness in diabetes. Diabetes 2008, 57(9):2488-2494.
40. Livrea M.A., et al. Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants. Blood 1996, 88:3608-3614.
41. Lyden D., et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 2001, 7:1194-1201.
42. McAllister S.S., et al. Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell 2008, 133:994-1005.
43. Mendez-Ferrer S., Frenette P.S. Galpha(s) uncouples hematopoietic stem cell homing and mobilization. Cell Stem Cell 2009, 4:379-380.
44. Minami E., et al. Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart. Circulation 2005, 112:2951-2958.
45. Moldovan N.I., Asahara T. Role of blood mononuclear cells in recanalization and vascularization of thrombi: past, present, and future. Trends Cardiovasc. Med. 2003, 13:265-269.
46. Moldovan N.I., et al. Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium. Circ. Res. 2000, 87:378-384.
47. Murdoch C., et al. The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 2008, 8:618-631.
48. Nozawa H., et al. Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma. Cancer Sci. 2006, 97:1115-1124.
49. Ohga N., et al. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells. Cancer Sci. 2009, 100:1963-1970.
50. Otani A., et al. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat. Med. 2002, 8:1004-1010.
51. Perk J., et al. Id family of helix-loop-helix proteins in cancer. Nat. Rev. Cancer 2005, 5:603-614.
52. Peters B.A., et al. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat. Med. 2005, 11:261-262.
53. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 2004, 4:71-78.
54. Poole J.C., Florey H.W. Changes in the endothelium of the aorta and the behaviour of macrophages in experimental atheroma of rabbits. J. Pathol. Bacteriol. 1958, 75:245-251.
55. Portillo J.A., et al. CD40 mediates retinal inflammation and neurovascular degeneration. J. Immunol. 2008, 181:8719-8726.
56. Purhonen S., et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:6620-6625.
57. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 2003, 9:702-712.
58. Ritter M.R., et al. Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J Clin Invest. 2006, 116:3266-3276.
59. Schatteman G.C., et al. Biology of bone marrow-derived endothelial cell precursors. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H1-H18.
60. Segal M.S., et al. Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes 2006, 55:102-109.
61. Shaked Y., et al. Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006, 313:1785-1787.
62. Shaked Y., et al. Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell 2008, 14:263-273.
63. Smith L.E., et al. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol. Vis. Sci. 1994, 35:101-111.
64. Song S., et al. PDGFRbeta+perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival. Nat. Cell Biol. 2005, 7:870-879.
65. Soucek L., et al. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat. Med. 2007, 13:1211-1218.
66. Spring H., et al. Chemokines direct endothelial progenitors into tumor neovessels. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:18111-18116.
67. Stockmann C., et al. Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis. Nature 2008, 456:814-818.
68. Thill M., et al. Late outgrowth endothelial progenitor cells in patients with age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2008, 49:2696-2708.
69. van Beem R.T., et al. Elevated endothelial progenitor cells during painful sickle cell crisis. Exp. Hematol. 2009, 37:1054-1059.
70. Wilson A., Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat. Rev. Immunol. 2006, 6:93-106.
71. Yang L., et al. Expansion of myeloid immune suppressor Gr+CD11b+cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell 2004, 6:409-421.
72. Yin T., Li L. The stem cell niches in bone. J. Clin. Invest. 2006, 116:1195-1201.
73. Yoder M.C., et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007, 109:1801-1809.